✦ LIBER ✦

Toxicity Profile and Adherence to the Pharmacotherapeutic Regimen of Gemcitabine–carboplatin in Non-small Cell Lung Cancer

✍ Scribed by Gómez Herrero, D.; Albert Marí, A.; Merino Sanjuán, M.; Boquera Ferrer, M.L.; Víctor Jiménez Torres, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Past, present, and future of gemcitabine

✍ Edelman, Martin J 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Gemcitabine and Carboplatin Regimens in

✍ Martin J. Edelman 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB

The development of gemcitabine and carbo

✍ Cullen, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Carboplatin (C) and Gemcitabine (G) in a

✍ Domine, M; Casado, V; Estevez, L.G; Leon, A; Martin, J.I; Castillo, M; Robles, L 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A phase II trial of Paclitaxel, Carbopla

✍ Almenarez, J; Murias, A; Garcia, I; Molano, F; Aguiar, J; Bohn, U; Camacho, M.C; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Gemcitabine and carboplatin in the treat

✍ Chai-Hooi LEOW; Chong-Kin LIAM 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB